Colgate-Palmolive (NYSE:CL) Shares Purchased by Mount Yale Investment Advisors LLC

Mount Yale Investment Advisors LLC lifted its stake in Colgate-Palmolive (NYSE:CL) by 5.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,299 shares of the company’s stock after acquiring an additional 173 shares during the period. Mount Yale Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $300,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in CL. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the third quarter valued at $42,000. Capital Performance Advisors LLP bought a new position in shares of Colgate-Palmolive in the third quarter valued at $53,000. Prospera Private Wealth LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $64,000. Finally, True Wealth Design LLC grew its holdings in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after acquiring an additional 672 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

CL stock opened at $89.65 on Thursday. The firm has a 50 day moving average of $91.67 and a two-hundred day moving average of $97.34. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30. The company has a market capitalization of $73.24 billion, a price-to-earnings ratio of 25.69, a P/E/G ratio of 3.59 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.23%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.

Wall Street Analyst Weigh In

CL has been the subject of several analyst reports. Piper Sandler reduced their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. TD Cowen reduced their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday. UBS Group reduced their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. Finally, Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $102.00.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.